Documents
Briefs, oral arguments, agency decisions and the Federal Register.
48 results
0.07s
UNITED STATES OF AMERICA (2025)
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborer’s Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionAgency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionUNITED STATES OF AMERICA (2025)
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionUNITED STATES OF AMERICA (2025)
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionUNITED STATES OF AMERICA (2025)
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionAgency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionAgency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012); see also Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharms., Inc., No. 24-CV-10565-DJC, 2025 WL 928747, at *20 (D. Mass. … Amneal Pharms. of N.Y., LLC, No. 24-1936 (Fed. Cir. Sept. 6, 2024), ECF No. 62; see also Mem. of Law of Amicus Curiae the Federal Trade Commission in Opp’n to Defs.’
Federal Trade CommissionCase: 24-1585, 09/24/2024, DktEntry: 37.1, Page 1 of 36
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399 (2012) .................................................................................. 3 FTC v. … Novo Nordisk A/S, 566 U.S. 399, 408 (2012); King Drug Co. of Florence, Inc. v.
Federal Trade CommissionAgency decision · Agency decision
Inc., 399 F.3d 181, 193–94 (3d Cir. 2005)). … Dentsply, 399 F.3d at 193; Minn. Mining & Mfg. Co. v. Appleton Papers, Inc., 35 F. Supp. 2d 1138, 1144 (D. Minn. 1999).
Federal Trade CommissionUNITED STATES DISTRICT COURT (2023)
Agency decision · Agency decision
Dentsply Int’l, Inc., 399 F.3d 181, 194 (3d Cir. 2005). Next, Eisai, Inc. v. … Dentsply, 399 F.3d at 194; see ¶ 115. The shorter formal length of each contract is thus “no ground to doubt the [program’s] effectiveness.” Dentsply, 399 F.3d at 193.
Federal Trade CommissionAgency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399 (2012) ............................................................................... 2 Cesar Castillo, Inc. v. … Novo Nordisk A/S, 566 U.S. 399, 400, 408 (2012) (citing Commission study findings as “evidence … that some brands were exploiting [the Hatch Waxman] statutory scheme to prevent or delay the marketing
Federal Trade CommissionCase: 23-55662, 01/26/2024, ID: 12853101, DktEntry: 24, Page 1 of 40
Agency decision · Agency decision
Dentsply Int’l, Inc., 399 F.3d 181 (3d Cir. 2005) ....................................................................... 11, 13 United States v. … ECF 198, at 24-26.
Federal Trade CommissionFraud and Identity Theft Complaints Received (2005)
Agency decision · Agency decision
No. of Complaints 2003 1,350 458 321 2,127 2004 1,819 623 529 2,964 2005 1,918 604 556 3,064 Indiana Calendar Year 50 - 59 60 - 69 70 and Over No. of Complaints 2003 673 224 219 1,113 2004 954 399 … Over No. of Complaints 2003 208 109 78 395 2004 300 122 98 520 2005 369 170 102 641 2003 28 11 5 44 Calendar Year 2004 60 23 12 95 2005 69 18 11 98 2003 697 364 221 1,282 Calendar Year 2004 801 399
Federal Trade CommissionAgency decision · Agency decision
Nos. 24-6256, 24-6274 IN THE United States Court of Appeals for the Ninth Circuit EPIC GAMES, INC., Plaintiff-Appellee, v. GOOGLE LLC, et al., Defendants-Appellants. On Appeal from the U.S. … # $& & ' #$"%$ # "$# " $$ ''' %# %"$# & " # " #$"%$ # & ' )" &'24-6256, 24-6274 ( ### ! ( !" ! !" # !
Federal Trade CommissionFederal Trade Commission Statement Concerning Brand Drug Manufacturers’
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399, 408 (2012). 20 FED. … Reg. 36,676 (June 18, 2003) (codified at 21 C.F.R. pt. 314). 24 See Fed. Trade Comm’n Generic Drug Entry Study, supra note 20. 22 4 IV.
Federal Trade CommissionAgency decision · Agency decision
Lab’ys, LLC, 173 F.T.C. 983, 984, 2022 WL 248146, at *1 (2022) (citing Champion Home Builders Co., 99 F.T.C. 397, 399 (1982)); see also James Carpets, Inc., 81 F.T.C. 1043, 1972 WL 128887 at *2 (1972) … misrepresented as required. c) At least 73% of consumers who purchased a vehicle at McDavid Honda Irving were charged for at least one add-on that they did not agree to buy or that was misrepresented as required. 24
Federal Trade CommissionCase 2:23-cv-20964-SRC-MAH Document 61-1 Filed 03/22/24 Page 1 of 47 PageID: 1975
Agency decision · Agency decision
Novo Nordisk A/S, 566 U.S. 399 (2012) .........................................................................................9, 37 Decision & Order, In re Biovail Corp., FTC Dkt. No. … Novo Nordisk A/S, 566 U.S. 399, 405-6 (2012). 18 9 Case 2:23-cv-20964-SRC-MAH Document 61-1 Filed 03/22/24 Page 17 of 47 PageID: 1991 manufacturers the power to trigger an automatic delay of FDA approval
Federal Trade CommissionIN THE UN ITED STATES DISTRICT COURT (2024)
Agency decision · Agency decision
Dentsply Int ' l , Inc ., 399 F . 3d 181, 187 (3d Cir . 2005) (quoting 16 Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 16 of 88 United States v. 2001)). … F.3d at 193-94 conditioned on See Dentsply , 399 (finding "strong economic incentive to continue" compliance with market-share agreement despite "legal which the relationship can be terminated");
Federal Trade CommissionAgency decision · Agency decision
Paulk, 611 F.3d 828, 850 & n.24 (11th Cir. 2010), aff’d, 566 U.S. 356 (2012); Thompson v. Hall, 426 F. App’x 855, 858 (11th Cir. 2011) (per curiam) (same). … Disp., No. 24-mc-32 (TNM), 2024 WL 3359515, at *3 (D.D.C.
Federal Trade CommissionAgency decision · Agency decision
Paulk, 611 F.3d 828, 850 & n.24 (11th Cir. 2010), aff’d, 566 U.S. 356 (2012); Thompson v. Hall, 426 F. App’x 855, 858 (11th Cir. 2011) (per curiam) (same). … Bailey, No. 24-cv-147, 2024 WL 3924573, at *12-13 (D.D.C.
Federal Trade Commission
Ask Donna what matters in the record.
She can read the source against your case and show you exactly where the answer came from.